Ian F. Smith

Ian F. Smith

DirectoratFoghorn Therapeutics· In proxies 2023–2025

Ian F. Smith sits on 7 public boards.

Boards1

  • Foghorn TherapeuticsDirector · 4 yr on the boardIndependentCompensation—Paid as an executive

Board seats come from each company's latest proxy statement.

Experience

  1. Foghorn TherapeuticsPublic company · 3 yr
    • Director2023 – Present · 3 yrStock in role -61%
  2. Odyssey TherapeuticsPublic company · 2 yr
    • Director2024 – Present · 2 yrNo stock prices for these years
  3. Rivus PharmaceuticalsPublic company · 3 yr
    • Director2023 – Present · 3 yrNo stock prices for these years
  4. Stoke TherapeuticsPublic company · 3 yr
    • Director2023 – Present · 3 yrNo stock prices for these years
  5. iVexSol Inc.Public company · 3 yr
    • Director2023 – Present · 3 yrNo stock prices for these years
  6. Alkeus PharmaceuticalsPublic company · 4 yr
    • Director2022 – Present · 4 yrNo stock prices for these years
  7. Solid BiosciencesPublic company · 6 yr
    • Director2020 – Present · 6 yrNo stock prices for these years

Roles come from the proxy statements of each company.

Activity

No new filings about this person in the feed.

Two people shown as one, or a wrong number?